Zadesenets K S, Rubtsov N B
Institute of Cytology and Genetics of the Siberian Branch of the Russian Academy of Sciences, Novosibirsk, Russia Novosibirsk State University, Novosibirsk, Russia.
Vavilovskii Zhurnal Genet Selektsii. 2025 Jun;29(3):335-348. doi: 10.18699/vjgb-25-37.
Aneuploidy is defined as the loss or gain of a whole chromosome or its region. Even at early stages of development, it usually leads to fatal consequences, including developmental defects/abnormalities and death. For a long time, it was believed that the disruption of gene balance results in pronounced effects at both the cellular and organismal levels, adversely affecting organism formation. It has been shown that the gene imbalance resulting from aneuploidy leads to proteotoxic and metabolic stress within the cell, reduced cell proliferation, genomic instability, oxidative stress, etc. However, some organisms have exhibited tolerance to aneuploidies, which may even confer adaptive advantages, such as antibiotic resistance in pathogenic fungal strains. A significant factor likely lies in the complexity of the tissue and organ organization of specific species. Polyploid organisms are generally more tolerant of aneuploidy, particularly those that have recently undergone whole-genome duplication. This review places special emphasis on the examination of sex chromosome aneuploidies in humans. In addition to primary effects, or cis effects (changes in the quantity of the transcripts of genes located on the aneuploid chromosome), aneuploidy can induce secondary or trans effects (changes in the expression levels of genes located on other chromosomes). The results of recent studies have prompted a reevaluation of the impact of aneuploidy on the structural-functional organization of the genome, transcriptome, and proteome of both the cell and the entire organism. Despite the fact that, in the cases of aneuploidy, the expression levels for most genes correlate with their altered copy numbers in the cell, there have been instances of dosage compensation, where the transcript levels of genes located on the aneuploid chromosome remained unchanged. The review presents findings from recent studies focused on compensatory mechanisms of dosage compensation that modify gene product quantities at post-transcriptional and post-translational levels, alleviating the negative effects of aneuploidy on cellular homeostasis. It also discusses the influence of extrachromosomal elements on the spatial organization of the genome and the changes in gene expression patterns resulting from their presence. Additionally, the review specifically examines cases of segmental aneuploidy and changes in copy number variants (CNVs) in the genome. Not only the implications of their composition are considered, but also their localization within the chromosome and in various compartments of the interphase nucleus. Addressing these questions could significantly contribute to enhancing cytogenomic diagnostics and establishing a necessary database for accurate interpretation of identified cases of segmental aneuploidy and CNVs in the genome.
非整倍体被定义为整条染色体或其区域的丢失或增加。即使在发育早期,它通常也会导致致命后果,包括发育缺陷/异常和死亡。长期以来,人们认为基因平衡的破坏会在细胞和机体水平上产生显著影响,对机体形成产生不利影响。研究表明,非整倍体导致的基因失衡会导致细胞内的蛋白毒性和代谢应激、细胞增殖减少、基因组不稳定、氧化应激等。然而,一些生物体表现出对非整倍体的耐受性,这甚至可能赋予适应性优势,例如致病真菌菌株中的抗生素抗性。一个重要因素可能在于特定物种的组织和器官组织的复杂性。多倍体生物通常对非整倍体更具耐受性,尤其是那些最近经历了全基因组复制的生物。本综述特别强调对人类性染色体非整倍体的研究。除了主要效应或顺式效应(位于非整倍体染色体上的基因转录本数量的变化)外,非整倍体还可诱导次要或反式效应(位于其他染色体上的基因表达水平的变化)。最近的研究结果促使人们重新评估非整倍体对细胞和整个生物体的基因组、转录组和蛋白质组的结构-功能组织的影响。尽管在非整倍体情况下,大多数基因的表达水平与其在细胞中改变的拷贝数相关,但也存在剂量补偿的情况,即位于非整倍体染色体上的基因转录水平保持不变。本综述介绍了最近的研究结果,这些研究集中在剂量补偿的补偿机制上,这些机制在转录后和翻译后水平上调节基因产物的数量,减轻非整倍体对细胞稳态的负面影响。它还讨论了染色体外元件对基因组空间组织的影响以及它们的存在导致的基因表达模式的变化。此外,本综述特别研究了节段性非整倍体的情况以及基因组中拷贝数变异(CNV)的变化。不仅考虑了它们的组成的影响,还考虑了它们在染色体和间期细胞核的各个隔室中的定位。解决这些问题可能会显著有助于加强细胞基因组诊断,并建立一个必要的数据库,以便准确解释基因组中已确定的节段性非整倍体和CNV病例。